- English
- 简体中文
- Español
- Português
- русский
- Français
- 日本語
- Deutsch
- tiếng Việt
- Italiano
- Nederlands
- ภาษาไทย
- Polski
- 한국어
- Svenska
- magyar
- Malay
- বাংলা ভাষার
- Dansk
- Suomi
- हिन्दी
- Pilipino
- Türkçe
- Gaeilge
- العربية
- Indonesia
- Norsk
- تمل
- český
- ελληνικά
- український
- Javanese
- فارسی
- தமிழ்
- తెలుగు
- नेपाली
- Burmese
- български
- ລາວ
- Latine
- Қазақша
- Euskal
- Azərbaycan
- Slovenský jazyk
- Македонски
- Lietuvos
- Eesti Keel
- Română
- Slovenski
- मराठी
- Srpski језик
China APIs Category Manufacturer
Active Pharmaceutical Ingredients
| Progestogen and Estrogen | |||
| Product Name | Specification | Approved | CAS No. |
| Progesterone | CP/EP/USP/JP | CEP/EU-GMP/FDA | 57-83-0 |
| Pregnenolone |
In-house |
Kosher | 145-13-1 |
| Medroxyprogesterone Acetate | CP/EP/USP/JP | DMF/GMP | 71-58-9 |
| Megestrol Acetate | CP/EP/USP | DMF in process | 595-33-5 |
| Mifepristone | CP/IP | DMF/GMP | 84371-65-3 |
| Cyproterone Acetate | CP/EP/IP/KP | CEP/TGA/EU-GMP | 427-51-0 |
| Levonorgestrel | CP/EP/USP/IP | CEP/GMP | 797-63-7 |
|
Norethisterone |
CP/EP/USP/JP |
DMF in process |
68-22-4 |
|
Norethisterone Acetate |
EP/USP |
DMF in process |
51-98-9 |
|
Norethisterone Enanthate |
In-house |
Under R&D |
3836-23-5 |
| Drospirenone | EP/USP | DMF | 67392-87-4 |
| Gestodene | CP/EP | DMF/GMP | 60282-87-3 |
| Estradiol | CP/EP/USP/KP | DMF/GMP/WC | 35380-71-3 |
| Estriol | CP/EP/USP | Under R&D | 50-27- 1 |
| Ethinyl Estradiol | CP/EP/USP | GMP | 57-63-6 |
| Estradiol Valerate | CP/EP/USP/KP | DMF | 979-32-8 |
|
Estradiol Cypionate |
USP |
DMF in process |
313-06-4 |
| Tibolone | CP/EP | DMF/GMP | 5630-53-5 |
| Dienogest | EP | CEP/GMP | 65928-58-7 |
| Fulvestrant | EP/USP | Under R&D | 129453-61-8 |
| Exemestane | CP/EP/USP | Under R&D | 107868-30-4 |
| Androgen | |||
| Product Name | Specification | Approved | CAS No. |
| Finasteride | CP/EP/USP | CEP/FDA/PMDA/GMP | 98319-26-7 |
| Dutasteride | EP/USP | CEP/FDA | 164656-23-9 |
| Abiraterone Acetate | CP/USP | DMF/WC | 154229-18-2 |
|
Darolutamide |
In-house |
Under R&D |
1297538-32-9 |
| Testosterone | CP/EP/USP | CEP/WC/FDA | 58-22-0 |
| Testosterone Undecanoate | CP | DMF/WC | 5949-44-0 |
| Testosterone Cypionate | USP | Under R&D | 58-20-8 |
|
Testosterone Enanthate |
USP/JP |
Under R&D |
315-37-7 |
|
Testosterone Propionate |
CP/EP/USP/JP |
Under R&D |
57-85-2 |
| DHEA(Prasterone) | FP/In-house | DMF/WC/Kosher | 53-43-0 |
| Clascoterone | In-house | DMF in process | 19608-29-8 |
| Cortical Hormone | |||
| Product Name | Specification | Approved | CAS No. |
| Budesonide | CP/EP/USP/JP | CEP/FDA/GMP | 51333-22-3 |
| Desonide | CP/USP | DMF/GMP | 638-94-8 |
| Eplerenone | EP | CEP in process | 107724-20-9 |
| Methylprednisolone | CP/EP/USP/JP | DMF/GMP | 83-43-2 |
| Methylprednisolone Hemisuccinate | CP/EP/USP | DMF/GMP | 2921-57-5 |
| Fluticasone Propionate | CP/EP/USP | DMF | 80474- 14-2 |
| Fluticasone Furoate | CP/EP | DMF in process | 397864-44-7 |
|
Mometasone Furoate |
CP/EP/USP |
DMF in process |
Anhydrous (83919-23-7) Monohydrate (141646-00-6) |
|
Deflazacort |
In-house |
Under R&D |
14484-47-0 |
| Others | |||
| Product Name | Specification | Approved | CAS No. |
| Oxcarbazepine | CP/EP/USP/IP | CEP/FDA/GMP | 28721-07-5 |
| Eslicarbazepine Acetate | CP/USP | DMF | 236395- 14-5 |
| Ganciclovir | CP/EP/USP | DMF/GMP | 82410-32-0 |
| Valganciclovir Hydrochloride | USP/EP | CEP in process | 175865-59-5 |
| Oseltamivir Phosphate | CP/EP/USP | DMF | 204255- 11-8 |
| Baloxavir Marboxil | In-house | Under R&D | 1985606-14-1 |
| Revefenacin | In-house | DMF | 864750-70-9 |
| Mirabegron | CP/EP | DMF | 223673-61-8 |
|
Vibegron |
In-house |
Under R&D |
1190389-15-1 |
| Escitalopram Oxalate | CP/EP/USP | DMF in process | 219861-08-2 |
|
Citalopram Hydrobromide |
CP/EP/USP |
DMF in process |
59729-32-7 |
| Cariprazine Hydrochloride | In-house | DMF | 1083076-69-0 |
| Lasmiditan Succinate | In-house | DMF | 439239-92-6 |
| Luliconazole | In-house | DMF | 187164-19-8 |
| Apalutamide | In-house | DMF | 956104-40-8 |
| Tadalafil | CP/EP/USP | Under R&D | 171596-29-5 |
| Relugolix | In-house | DMF in process | 737789-87-6 |
|
Ruxolitinib phosphate |
In-house |
DMF in process |
1092939-17-7 |
|
Abemaciclib |
In-house |
Under R&D |
1231929-97-7 |
| Phloroglucinol | CP/EP | DMF | 108-73-6 |
|
1,3,5-Trimethoxybenzene |
CP/In-house |
GMP |
621-23-8 |
| Ursodeoxycholic Acid | EP/USP/JP | Under R&D | 128-13-2 |
|
Tauroursodeoxycholic Acid |
In-house |
Under R&D |
14605-22-2 |
|
Cholesterol |
CP/EP/USP/JP |
Under R&D |
57-88-5 |
|
Omega-3-Acid Ethyl Ethers 90 |
EP/USP |
DMF in process |
—— |
|
Medium-Chain Triglycerides |
CP/USP/EP |
DMF |
—— |
|
Benzalkonium Chloride |
USP/EP/JP |
CEP in process |
8001-54-5 |
|
Olive Oil (For Injection) |
CP/USP/EP/JP |
DMF in process |
8001-25-0 |
|
Egg phospholipids (For Injection) |
CP/USP/EP |
DMF |
93685-90-6 |
|
SNAC |
In-house |
DMF in process |
203787-91-1 |
- View as
Fluticasone Furoate
Fluticasone furoate has In-house specifications. DMF under filing.
CAS:397864-44-7
Read MoreSend Inquiry
Mometasone Furoate
Mometasone furoate has CP、EP、USP specifications. DMF under filing.
CAS:83919-23-7
Read MoreSend Inquiry
Eslicarbazepine Acetate
Eslicarbazepine Acetate has In-house specification. DMF approved.
CAS:236395-14-5
Read MoreSend Inquiry
Valganciclovir Hydrochloride
Valganciclovir Hydrochloride has USP specification. DMF approved.
CAS:175865-59-5
Read MoreSend Inquiry
Oseltamivir Phosphate
Oseltamivir Phosphate has CP ,EP and USP specifications. DMF available.
CAS:204255-11-8
Read MoreSend Inquiry
Revefenacin
Revefenacin has In-house specification. DMF approved.
CAS:864750-70-9
Read MoreSend Inquiry
Humanwell Pharmaceutical is one of the largest API manufacture in China. With more than 20 years of experience, we develop, manufacture and trade steroid APIs, intermediates and formulations. Our market covers all over the world, we have strong presences in North America, Europe, South America and Africa, with products sold to more than 150 countries.
